Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.665
+0.115 (4.51%)
Apr 19, 2024, 2:22 PM EDT - Market closed

Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $96.34 million. The enterprise value is $197.46 million.

Market Cap 96.34M
Enterprise Value 197.46M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

ARMP has 36.15 million shares outstanding. The number of shares has increased by 5.19% in one year.

Shares Outstanding 36.15M
Shares Change (YoY) +5.19%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 70.35%
Owned by Institutions (%) 3.63%
Float 10.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 21.27
Forward PS 20.52
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 43.60
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.16

Current Ratio 1.16
Quick Ratio 1.37
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -25.29

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -65.60%
Return on Capital (ROIC) -46.30%
Revenue Per Employee $68,621
Profits Per Employee -$1.05M
Employee Count 66
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +64.61% in the last 52 weeks. The beta is 0.70, so ARMP's price volatility has been lower than the market average.

Beta (1Y) 0.70
52-Week Price Change +64.61%
50-Day Moving Average 3.50
200-Day Moving Average 2.93
Relative Strength Index (RSI) 31.57
Average Volume (30 Days) 16,285

Short Selling Information

The latest short interest is 14,148, so 0.04% of the outstanding shares have been sold short.

Short Interest 14,148
Short Previous Month 29,623
Short % of Shares Out 0.04%
Short % of Float 0.13%
Short Ratio (days to cover) 0.73

Income Statement

In the last 12 months, ARMP had revenue of $4.53 million and -$69.05 million in losses. Loss per share was -$1.91.

Revenue 4.53M
Gross Profit 4.53M
Operating Income -40.89M
Pretax Income -69.05M
Net Income -69.05M
EBITDA -65.45M
EBIT -66.42M
Loss Per Share -$1.91
Full Income Statement

Balance Sheet

The company has $19.24 million in cash and $120.37 million in debt, giving a net cash position of -$101.13 million or -$2.80 per share.

Cash & Cash Equivalents 19.24M
Total Debt 120.37M
Net Cash -101.13M
Net Cash Per Share -$2.80
Equity / Book Value -32.07M
Book Value Per Share -0.89
Working Capital 2.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.42 million and capital expenditures -$8.13 million, giving a free cash flow of -$55.56 million.

Operating Cash Flow -47.42M
Capital Expenditures -8.13M
Free Cash Flow -55.56M
FCF Per Share -$1.54
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -902.85% and -1,524.51%.

Gross Margin 100.00%
Operating Margin -902.85%
Pretax Margin -1,524.51%
Profit Margin -1,524.51%
EBITDA Margin -1,445.07%
EBIT Margin -1,466.53%
FCF Margin -1,226.69%

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.19%
Shareholder Yield -5.19%
Earnings Yield -71.67%
FCF Yield -57.67%

Analyst Forecast

The average price target for ARMP is $7.00, which is 162.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 162.66%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 65.52%
EPS Growth Forecast (5Y) -46.77%
Stock Forecasts

Stock Splits

The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:14.

Last Split Date May 10, 2019
Split Type Reverse
Split Ratio 1:14

Scores

ARMP has an Altman Z-Score of -6.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.1
Piotroski F-Score 2